Yung-Chi Cheng Selected Research

4'-ethynylstavudine

4/2009

Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yung-Chi Cheng Research Topics

Disease

41	Neoplasms (Cancer) 01/2021 - 09/2003
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2004
6	Infections 01/2021 - 11/2004
5	Diarrhea 01/2021 - 09/2007
5	Inflammation (Inflammations) 01/2019 - 03/2006
4	Vomiting 01/2021 - 09/2007
4	Weight Loss (Weight Reduction) 01/2013 - 09/2007
4	Colorectal Neoplasms (Colorectal Cancer) 06/2011 - 05/2006
3	Liver Neoplasms (Liver Cancer) 01/2019 - 10/2009
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 10/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2014 - 10/2006
2	Nausea 01/2021 - 04/2012
2	Body Weight (Weight, Body) 01/2018 - 12/2014
2	Arthritis (Polyarthritis) 01/2017 - 03/2006
2	Colonic Neoplasms (Colon Cancer) 12/2014 - 09/2007
2	Hypoxia (Hypoxemia) 08/2011 - 02/2009
2	Nasopharyngeal Carcinoma 07/2006 - 01/2004
1	Hyperthermia 03/2021
1	Pain (Aches) 01/2021
1	Fatigue 01/2021
1	Dysmenorrhea (Menstrual Pain) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	COVID-19 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hyperglycemia 01/2020
1	Obesity 01/2020
1	Intestinal Diseases (Diseases, Intestinal) 01/2019
1	Ulcerative Colitis 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Genomic Instability 09/2015
1	Necrosis 01/2015
1	Chronic Hepatitis B 11/2014
1	Cachexia 02/2014
1	Hyperplasia 01/2013

Drug/Important Bio-Agent (IBA)

14	PHY 906IBA 01/2021 - 01/2007
9	Pharmaceutical PreparationsIBA 01/2021 - 12/2006
7	tylophorineIBA 01/2017 - 01/2004
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 08/2010
4	DeoxycytidineIBA 02/2009 - 08/2004
4	troxacitabineIBA 02/2009 - 08/2004
4	NF-kappa B (NF-kB)IBA 09/2008 - 08/2005
3	Capecitabine (Xeloda)FDA Link 01/2021 - 10/2009
3	Therapeutic UsesIBA 01/2021 - 10/2006
3	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2004
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 04/2012
3	NucleosidesIBA 11/2014 - 09/2003
3	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 07/2006
2	SugarsIBA 03/2021 - 01/2019
2	baicaleinIBA 01/2019 - 09/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 02/2014
2	Cyclin D1IBA 01/2016 - 10/2006
2	NucleotidesIBA 11/2014 - 09/2003
2	Gemcitabine FDA Link 02/2014 - 02/2009
2	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 07/2006
2	Fluorouracil (Carac)FDA LinkGeneric 06/2011 - 05/2009
2	EnzymesIBA 09/2010 - 09/2003
2	Stavudine (Zerit)FDA LinkGeneric 04/2009 - 05/2004
2	Biological ProductsIBA 04/2008 - 10/2006
2	DCB 3503IBA 08/2007 - 03/2006
1	BilirubinIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	Plant ExtractsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	BradykininIBA 01/2020
1	Gallic AcidIBA 01/2020
1	LipidsIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2019
1	sulforaphaneIBA 01/2019
1	honokiolIBA 01/2019
1	baicalinIBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2017
1	Glutathione (Reduced Glutathione)IBA 12/2017
1	PoisonsIBA 12/2017
1	SaponinsIBA 01/2016
1	pyrophosphomevalonate decarboxylase (diphosphomevalonate decarboxylase)IBA 09/2015
1	Sorafenib (BAY 43-9006)FDA Link 03/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2015
1	purineIBA 02/2015
1	malformin CIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2021 - 08/2004
8	Therapeutics 01/2021 - 01/2007
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 05/2011
3	Radiotherapy 01/2021 - 02/2009
2	Immunotherapy 01/2021 - 01/2018
2	Complementary Therapies (Alternative Medicine) 01/2019 - 11/2017
2	Injections 08/2007 - 01/2004
1	Salvage Therapy 01/2021